Format

Send to

Choose Destination
Expert Rev Anti Infect Ther. 2008 Jun;6(3):373-84. doi: 10.1586/14787210.6.3.373.

Management of fungal infections following allogeneic stem cell transplantation.

Author information

1
Division of The Strategic Outcome Research Program for Cancer Control MHLW-commission, Japan Cancer Society, Yurakucho Center Bldg. (Mullion) 13F, 2-5-1, Yurakucho Chiyoda-ku Tokyo, 100-0006, Japan. hiroto-narimatsu@umin.net

Abstract

Fungal infection remains an important complication in allogeneic stem cell transplantation (allo-SCT). Since the prognosis of fungal infection is poor, prophylaxis is critical for its management; owing to recent progression in allo-SCT management and widespread use of reduced-intensity regimens, the strategy of infectious prophylaxis has also changed. Various antifungals have recently been developed and applied to clinical use. A major change in antifungal management will probably occur in the next few years.

PMID:
18588501
DOI:
10.1586/14787210.6.3.373
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center